Butterfly Network’s new CEO, Joseph DeVivo, has inherited a mixed bag from the company’s previous leadership.
He will collect a generous salary – $875,000 per year, an annual bonus worth up to 125% of that, a...
After Floating To Butterfly Network, CEO DeVivo Is Ready To Sting Like A Bee
Listen to this article
He may not be Ali, but Butterfly Network's new CEO, Joseph DeVivo, believes Butterly’s microchip tech packs a formidable punch. He expects the company’s technology will help it transcend the market-development challenges the company faced under its previous leaderships.
Keep up with the top medtech business and regulatory news.
More from Diagnostic Imaging
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
• By
This week, Neuralink announced it received US FDA breakthrough device designation for a device to restore sight; medtechs Discure and DeepLook secured new funding; FDA pump recalls from B. Braun Medical and Fresenius Kabi; Axonics prevails in patent infringement lawsuit with Medtronic; Merit Medical buys Cook Medical for $210m.
• By
This week, a medical group sued the FDA to block a lab-developed test rule; the FDA published guidance on device classifications; Defibtec issued a recall of its chest compression device and ICU Medical updated instructions for its infusion pump batteries; Maui Imaging raised a $4m DOD grant to put imaging tech into military-based trauma units.
• By
Medtronic receives US FDA approval for deep brain stimulation surgery for people with Parkinson’s and essential tremors while the patient is under general anesthesia, making it the first and only company to offer DBS surgery while the patient is asleep.
More from Diagnostics
• By
This week, Neuralink announced it received US FDA breakthrough device designation for a device to restore sight; medtechs Discure and DeepLook secured new funding; FDA pump recalls from B. Braun Medical and Fresenius Kabi; Axonics prevails in patent infringement lawsuit with Medtronic; Merit Medical buys Cook Medical for $210m.
• By
With the reversal of the Chevron doctrine in June, lower courts will now have more say in deciding regulatory statutes when the language is murky. But will that open the door to more legal challenges from the healthcare industry against government regulations it finds unfavorable? A pair of legal experts recently discussed the potential implications of the Court’s decision.
• By
Inari Medical is updating use instructions for a clot-removing catheter due to the potential for serious adverse effects, including death.